Lanean...
Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?
Safety-tested modified vaccinia virus Ankara (MVA) has been established as a potent vector system for the development of candidate recombinant vaccines. The versatility of the vector system was recently demonstrated by the rapid production of experimental MVA vaccines for immunization against severe...
Gorde:
| Argitaratua izan da: | Curr Opin Biotechnol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Ltd.
2004
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7127071/ https://ncbi.nlm.nih.gov/pubmed/15560976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.copbio.2004.09.001 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|